Nothing Special   »   [go: up one dir, main page]

JPS60133887A - Production of elastase - Google Patents

Production of elastase

Info

Publication number
JPS60133887A
JPS60133887A JP23164584A JP23164584A JPS60133887A JP S60133887 A JPS60133887 A JP S60133887A JP 23164584 A JP23164584 A JP 23164584A JP 23164584 A JP23164584 A JP 23164584A JP S60133887 A JPS60133887 A JP S60133887A
Authority
JP
Japan
Prior art keywords
elastase
resultant
water
pancreas
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP23164584A
Other languages
Japanese (ja)
Other versions
JPS6054037B2 (en
Inventor
Tsuneo Miyake
三宅 常夫
Sanji Sato
佐藤 三治
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OOKURA SEIYAKU KK
Original Assignee
OOKURA SEIYAKU KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by OOKURA SEIYAKU KK filed Critical OOKURA SEIYAKU KK
Priority to JP23164584A priority Critical patent/JPS6054037B2/en
Publication of JPS60133887A publication Critical patent/JPS60133887A/en
Publication of JPS6054037B2 publication Critical patent/JPS6054037B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Enzymes And Modification Thereof (AREA)

Abstract

PURPOSE:To obtain industrially and advantageously the titled substance, useful for medicines, etc., by autolyzing the pancreas of a mammal, filtering the resultant autolyzate, adding an alkaline earth metal salt to the resultant autolyzate filtrate in the presence of a specific amount of a water-soluble organic solvent, removing the formed precipitates, and separating the resultant extract of elastase. CONSTITUTION:The pancreas of a mammal, e.g. a pig, are shredded, and autolyzed at 50 deg.C for 3hr with vigorous agitation. Water is added thereto to filter the resultant mixture. An alkaline earth metal salt, e.g. calcium acetate, is added to the resultant autolyzate filtrate in the presence of 10-30% water-soluble organic solvent, e.g. acetone, to give >=1% alkaline earth metal salt concentration. The formed precipitates are removed by centrifugation to separate an extract of elastase, which is then dialyzed to remove salts and organic solvents. Ammonium sulfate is then added to the dialyzate to saturation, and the formed precipitates are separated to afford the aimed substance.

Description

【発明の詳細な説明】 本発明はエラスターゼの製造方法に関する。[Detailed description of the invention] The present invention relates to a method for producing elastase.

エラスターゼは、咄乳動物膵臓中に存在している所謂セ
リンプロテアーゼの一種であるが、不溶性硬タンパク質
であるエラスチンを分解する、きわめて特異なプロテア
ーゼである。近年、エラスチンの分解現象と、加令、動
脈硬化症、あるいは肺気腫、1Ft−炎、血管炎、等と
の関係が注目されてオリ(金抜全う(、onnecti
ve Ti5sue 6 (1) 1 (1974))
、将来エラスターゼの医薬品としての利用が高まるもの
と考えられる。このような観点から、エラスターゼを効
率よ(工業的規模で製造する方法の開発が望まれている
Elastase is a type of so-called serine protease present in the pancreas of mammalian animals, and is an extremely unique protease that degrades elastin, which is an insoluble hard protein. In recent years, the relationship between elastin degradation and aging, arteriosclerosis, emphysema, 1Ft inflammation, vasculitis, etc. has attracted attention.
ve Ti5sue 6 (1) 1 (1974))
It is thought that the use of elastase as a medicine will increase in the future. From this point of view, it is desired to develop a method for producing elastase efficiently (on an industrial scale).

従来エラスターゼの製造方法に関して多くの報告がなさ
れているが、そのほとんどは研究室レベルでの製造方法
である。現在までに報告されているエラスターゼの製造
方法として最も代表的なものにしewisらの方法(J
 −Biol che+n 222705(1956)
)がある。
Many reports have been made regarding methods for producing elastase, but most of them are produced at the laboratory level. The most representative elastase production method reported to date is the method of Ewis et al.
-Biol che+n 222705 (1956)
).

この方法は、膵臓及びパンクレアチンの稀酢酸抽出物に
硫安を45%飽和に加えて、生じた沈澱を0.1 M炭
酸緩衝液に溶解し、次いで脱塩により生じるオイクロプ
リン画分を0.1 M炭酸塩緩衝液に溶解し、硫安を3
5%飽和に加えてエラスターゼの沈澱を得る。しかる後
、再び0.1M炭酸緩衝液に溶解して結晶化させるもの
である。
This method involves adding ammonium sulfate to dilute acetic acid extracts of pancreas and pancreatin to 45% saturation, dissolving the resulting precipitate in 0.1 M carbonate buffer, and then desalting the eicloprine fraction to 0.1 Dissolve ammonium sulfate in 3M carbonate buffer.
Obtain 5% saturation plus elastase precipitation. Thereafter, it is dissolved again in 0.1M carbonate buffer and crystallized.

特公昭50−21557にかかる方法はLew i s
らの方法の45%硫安飽和で得られる沈f殿をp H5
〜1Oの水溶液に溶解し、5〜50℃に1時間以上放置
した後に再度塩析することを特徴とするもので、基本的
にはLew i s らの方法と同様である。
The method according to Special Publication No. 50-21557 is Lewis
The precipitate obtained at 45% ammonium sulfate saturation in the method of et al.
The method is basically the same as the method of Lewis et al., which is characterized in that it is dissolved in an aqueous solution of ~1O, left at 5 to 50°C for 1 hour or more, and then salted out again.

特開昭52−110892にかかる方法は膵臓抽出液を
直接陽イオン交換体に作用させエラスターゼを吸着させ
た後、溶出し分画することを特徴とするものである。
The method disclosed in JP-A-52-110892 is characterized in that a pancreatic extract is directly applied to a cation exchanger to adsorb elastase, and then eluted and fractionated.

また特開昭52−61287では、膵臓に哺乳動物の十
二指腸あるいは、その抽出液を加えてエラスターゼ前駆
物質を活性化することを特徴とするエラスターゼの製造
方法を示している。
Furthermore, Japanese Patent Application Laid-Open No. 52-61287 discloses a method for producing elastase, which is characterized in that the duodenum of a mammal or an extract thereof is added to the pancreas to activate an elastase precursor.

上記の方法は、いずれも膵臓抽出液を得るための前処理
が全(なかったり、あるいはきわめて不十分であるため
、膵臓抽出液を収率よ(、し力)も清澄に得ることがき
わめて困難である。
In all of the above methods, the pretreatment for obtaining the pancreatic extract is either absent or extremely insufficient, making it extremely difficult to obtain a clear pancreatic extract with a good yield. It is.

それに加えて、抽出液のタンノ々りその他生体成分の含
量が多く、その後の精製過程に於て操作力≦煩雑となり
、高純度のエラスターゼを収率よく工業的な規模で製造
する方法としては十分とは言lJ)難い。
In addition, the extract contains a large amount of tannozuri and other biological components, and the subsequent purification process requires less effort and complexity, making it insufficient as a method to produce high-purity elastase on an industrial scale with good yield. It is difficult to say that.

これらの点に特に注意して研究した結果、高純度のエラ
スターゼを得る本発明を完成させるに至った。
As a result of research paying particular attention to these points, the present invention for obtaining highly pure elastase has been completed.

本発明は哺乳類の膵臓を20〜60℃好ましくは40〜
50°Cに少な(とも1時間界」ニ自己消化させたのち
、消化P液に10〜30%の水可溶性有機溶剤存在下に
アルカリ土類金属を1%以」二に加え、生じた沈澱を除
去してエラスターゼ抽出液を得ることを特徴とする。
In the present invention, the mammalian pancreas is heated at 20-60°C, preferably at 40-60°C.
After autolysis at 50°C for a short time (at least 1 hour), 1% or more of an alkaline earth metal was added to the digested P solution in the presence of a 10-30% water-soluble organic solvent, and the resulting precipitate was is removed to obtain an elastase extract.

必要によりこのエラスターゼ抽出液に対して、通常行な
われるとおり透析した後、硫安を25〜45%飽和好ま
しくは、35%飽和に加えて生じた沈澱1.H8−11
5の水に溶解した後、脱塩し、Hを中和することにより
エラスターゼが複合体を結晶として析出させ、或いは」
上記の脱塩の後弱塩基性陰イオン交換体に通じ、未吸着
画分を集めた後に中和することにより、純エラスターゼ
結晶を析出させることも出来る。
If necessary, this elastase extract is dialyzed as usual, and then ammonium sulfate is added to saturation of 25 to 45%, preferably 35%, and the resulting precipitate is 1. H8-11
After dissolving in water of 5, desalting and neutralizing H causes elastase to precipitate the complex as a crystal, or
After the above desalting, pure elastase crystals can be precipitated by passing through a weakly basic anion exchanger, collecting unadsorbed fractions, and then neutralizing them.

本発明にかかるエラスターゼは牛、豚、羊等、哺乳動物
の膵臓に含有されているが、特に豚膵臓に多量に存在し
ているため、工業的製造のための原料としては豚膵臓を
用いるのが有利である。
Elastase according to the present invention is contained in the pancreas of mammals such as cows, pigs, and sheep, but since it is present in particularly large amounts in pig pancreas, it is difficult to use pig pancreas as a raw material for industrial production. is advantageous.

精製エラスターゼは低温下ではPH4〜]、 0.5の
範囲できわめて安定であるが、20℃以」ニでは不安定
である事が知られている。しかし膵臓自己消化時に於け
るエラスターゼの安定性はきわめて高く、ブタ膵臓細切
物を20〜60℃で少なくとも1時間界」二例えば50
℃3時間の自己消化を行なった場合に於いても、公知の
方法(特開昭52−61287)と比較したかきり、は
とんどエラスターゼの分解が認められない事を発見した
Purified elastase is extremely stable at low temperatures in the pH range of 4 to 0.5, but is known to be unstable at temperatures below 20°C. However, the stability of elastase during pancreatic autolysis is extremely high;
It was discovered that even when autolysis was carried out for 3 hours at °C, no decomposition of elastase was observed compared to the known method (Japanese Unexamined Patent Publication No. 52-61287).

この条件で得られる自己消化液はきわめて粘性が低く、
従へてr過が速やかで且つ大量の清澄P液を得ることが
出来た。
The autolytic fluid obtained under these conditions has extremely low viscosity;
Therefore, the filtration was rapid and a large amount of clear P liquid could be obtained.

更に比較的高温度下での自己消化により、結合組織タン
パクその他の不要タンパクの多くが低分子化を受け、そ
の後のエラスターゼ製造工程に都合の良い消化P液を得
ることが出来た。
Furthermore, autolysis at a relatively high temperature reduced the molecular weight of many of the connective tissue proteins and other unnecessary proteins, making it possible to obtain a digested P solution that was convenient for the subsequent elastase production process.

自己消化清澄ρ液に、アルカリ土類金属を1%以上にな
る様に加えた後、エタノール、メタノール、アセトン等
、水可溶性有機溶剤を]0〜30%となる様に加えてタ
ンパク質沈澱を除去し、エラスターゼ含有溶液を得る。
After adding alkaline earth metals to the autolyzed clarified rho solution to a concentration of 1% or more, a water-soluble organic solvent such as ethanol, methanol, acetone, etc. is added to a concentration of 0 to 30% to remove protein precipitates. to obtain an elastase-containing solution.

ここで使用しうるアルカリ土類金属塩としては例えば塩
化カルシウム、塩化マグネシウム等の水溶性塩が有効で
ある。
As alkaline earth metal salts that can be used here, for example, water-soluble salts such as calcium chloride and magnesium chloride are effective.

本発明による上記方法とLewisらの方法とのエラス
ターゼ精製度を下表に参考として示した。
The elastase purification degrees of the above method according to the present invention and the method of Lewis et al. are shown in the table below for reference.

精製度はlewisらの方法によって得られたエラスタ
ーゼ含有溶液の粗抽出液の精製度を180としてその倍
率を示している。
The degree of purification is expressed as a magnification of 180, which is the degree of purification of the crude extract of the elastase-containing solution obtained by the method of Lewis et al.

本発明による LeWlSらの方法 方法の精製度 による精製度 エラスターゼ含有溶液 3.、O1,0硫安45%沈澱
 28 オイグロブリン沈澱 47 硫安35%沈澱 91 57 工ラスターピ複合体結晶 12,0 11.2但し本発
明方法により得られるエラスターゼのエラスチン分解能
の測定は、不溶性エラスチンの分解により生じる可溶性
エラスチン分解物の量をチロジン価として算出し、1分
間に1μグの千ロジンの遊離する活性を1単位とするR
Obl)lnSらの方法(Arch、 Biochem
、 Biophys、 66.396、(,1975)
)の改良法により測定した。
Purification according to the method of LeWlS et al. Purification according to the present invention Elastase-containing solution 3. , O1,0 45% ammonium sulfate precipitate 28 Euglobulin precipitate 47 Ammonium sulfate 35% precipitate 91 57 Elastapi complex crystal 12,0 11.2 However, the elastin decomposition ability of elastase obtained by the method of the present invention is measured by decomposing insoluble elastin. The amount of soluble elastin decomposition product produced is calculated as the tyrosine value, and the activity of releasing 1 μg of 1,000 rosin per minute is defined as R
Obl) lnS et al.'s method (Arch, Biochem
, Biophys, 66.396, (, 1975)
) was measured using a modified method.

タンパク質はLOWry法(J 、]3io1・che
m−193・265・(1951))に従い、卵白アル
ブミンを標準として定量した。
Proteins were obtained using the LOWry method (J,]3io1・che
193, 265, (1951)) using ovalbumin as a standard.

以下に本発明を実施例をもって更に詳細に説明する。The present invention will be explained in more detail below with reference to Examples.

豚膵臓細切1物1 K9を強く攪拌しながら50℃に3
時間自己消化にかけた後、31!の水を加え、ρ過によ
り、3.51の清澄を夜を得た。清澄液に8Oグの酢酸
カルシウムを加えたのち、アセトン500記を加えた。
1 minced pork pancreas 1 K9 at 50℃ with strong stirring 3
After 31 hours of autolysis! of water was added and a clearness of 3.51 was obtained by ρ filtration. After adding 80 grams of calcium acetate to the clear liquid, 500 grams of acetone was added.

生じる沈澱を遠心分離により除きエラスターゼ含有の遠
心上a3.31を得た。
The resulting precipitate was removed by centrifugation to obtain elastase-containing centrifuge a3.31.

該上清を透析して塩及び有機溶剤を除き、透析内液に固
形硫酸アンモニウムを35%飽和になるように溶解し、
生じた沈澱を遠心分離により集め、100−の水に懸濁
し、アンモニア水でPHを10に調節する事により沈澱
を溶解した。
The supernatant was dialyzed to remove salts and organic solvents, and solid ammonium sulfate was dissolved in the dialysis solution to a saturation of 35%.
The resulting precipitate was collected by centrifugation, suspended in 100-g water, and the precipitate was dissolved by adjusting the pH to 10 with aqueous ammonia.

溶液の、)Jを8〜11.5に保ちながら透析して脱塩
した後、酢酸で溶液の、Hを7にする事によりエラスタ
ーゼ複合体を晶出させた。結晶をρ過により集め冷蒸留
水で洗浄することにより、150単位/ myタンパク
のエラスターゼ複合体617を得た。
After desalting the solution by dialysis while maintaining J of 8 to 11.5, the elastase complex was crystallized by adjusting the H of the solution to 7 with acetic acid. The crystals were collected by ρ filtration and washed with cold distilled water to obtain elastase complex 617 of 150 units/my protein.

出願人 大蔵製薬株式会社Applicant: Okura Pharmaceutical Co., Ltd.

Claims (1)

【特許請求の範囲】 ■ 補乳動物の膵臓を自己消化させた後、消化ρ液に1
0〜30%の水可溶性有機溶剤存在下にアルカリ土類金
属塩を1%以上となる様に加え、生じた沈澱を除去して
エラスターゼ抽出液を得ることを特徴とするエラスター
ゼの製法。 ■ 膵臓の自己消化は40〜50℃に少なくとも1時間
以上行なう特許請求の範囲第1項の方法。
[Claims] ■ After autolyzing the pancreas of a feeder animal, 1
A method for producing elastase, which comprises adding an alkaline earth metal salt to a concentration of 1% or more in the presence of a 0 to 30% water-soluble organic solvent, and removing the resulting precipitate to obtain an elastase extract. (2) The method according to claim 1, wherein autolysis of the pancreas is carried out at 40 to 50°C for at least one hour.
JP23164584A 1984-11-02 1984-11-02 Manufacturing method of elastase Expired JPS6054037B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP23164584A JPS6054037B2 (en) 1984-11-02 1984-11-02 Manufacturing method of elastase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23164584A JPS6054037B2 (en) 1984-11-02 1984-11-02 Manufacturing method of elastase

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP11712179A Division JPS5642588A (en) 1979-09-11 1979-09-11 Production of elastase

Publications (2)

Publication Number Publication Date
JPS60133887A true JPS60133887A (en) 1985-07-17
JPS6054037B2 JPS6054037B2 (en) 1985-11-28

Family

ID=16926742

Family Applications (1)

Application Number Title Priority Date Filing Date
JP23164584A Expired JPS6054037B2 (en) 1984-11-02 1984-11-02 Manufacturing method of elastase

Country Status (1)

Country Link
JP (1) JPS6054037B2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61194132U (en) * 1985-05-23 1986-12-03
JPS61197429U (en) * 1985-05-29 1986-12-09
JPS62198440U (en) * 1986-06-05 1987-12-17
JPH01175242U (en) * 1988-06-01 1989-12-13

Also Published As

Publication number Publication date
JPS6054037B2 (en) 1985-11-28

Similar Documents

Publication Publication Date Title
SU1658820A3 (en) Method for preparing mucopolysaccharides
JP2622686B2 (en) Method for producing k-casein glycomacropeptide
JPS62294621A (en) Method for recovering albumin
DE69605152T2 (en) Crystalline valine p-isopropylbenzenesulfonate and a method for purifying valine
JPS60258123A (en) Method of obtaining factor xiii specimen and use
JPS60133887A (en) Production of elastase
EP1557472A1 (en) Sodium chondroitin sulfate, chondroitin sulfate-containing material and processes for producing the same
JPH06192296A (en) Production of crystal a type botulinus toxin as medicine for therapy
EP0089218B1 (en) A process for purifying human chorionic gonadotropin
EP0126887B1 (en) Process for obtaining pure l-leucine
CN108383927B (en) Chondroitin sulfate magnesium and preparation method thereof
JP2685424B2 (en) Protamine production method
US2650242A (en) Separation of tyrosine and cystine
EP0126886B1 (en) Process for the separation of l-leucine and l-isoleucine
EP0081831B1 (en) Process for purifying elastase
JPH07233147A (en) Production of purified l-hydroxyproline
JPH034532B2 (en)
JPS5840472B2 (en) Method for removing kinin-degrading enzyme from kallikrein-containing solution
JP2793158B2 (en) How to separate tyrosine from fibroin
EP0059182B1 (en) A process for isolating aminoacylase enzyme from a mammal kidney extract
JPH11180948A (en) Production of s-(1,2-dicarboxyethyl)glutathione
JPH0710821A (en) Production of tyrosine
JP3737252B2 (en) Method for recovering and purifying protein having epidermal growth factor activity
JP2757321B2 (en) Purification method of ellagic acid
JPH0825972B2 (en) Purification method of aspartic acid